These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 3764715)

  • 41. Propranolol and the morning increase in sudden cardiac death: (the beta-blocker heart attack trial experience).
    Peters RW
    Am J Cardiol; 1990 Nov; 66(16):57G-59G. PubMed ID: 2239715
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protection from morbidity and mortality from first infarcts: the case for beta-blockade.
    Lambert DM
    Aust Fam Physician; 1978 Jun; Suppl():5-10. PubMed ID: 708313
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of obzidan in the acute period of myocardial infarct].
    Gvatua NA; Kravtsov VL; Ivanova LK; Shkliar LV; Shumakov VA
    Kardiologiia; 1980 Oct; 20(10):19-24. PubMed ID: 7441957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of obzidan on the adenine nucleotide content of various areas of the heart in experimental myocardial infarct].
    Irgashev ShB; Iuldashev NM
    Farmakol Toksikol; 1987; 50(1):44-5. PubMed ID: 3556552
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of infarct size limitation by propranolol on ventricular arrhythmias after myocardial infarction.
    Stewart JR; Gibson JK; Lucchesi BR
    Ann N Y Acad Sci; 1982; 382():223-8. PubMed ID: 7044241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Results of prospective studies of patients with unstable angina pectoris treated by conservative methods].
    Gratsianskiĭ NA; Esenbaeva ZM; Zimin IuV; Kuznetsova GV; Miseiuk NK
    Kardiologiia; 1979 Aug; 19(8):73-7. PubMed ID: 114705
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Pharmacodynamic characteristics of a test using intravenous obzidan administration in patients with myocardial infarct].
    Parkhomenko AN
    Vrach Delo; 1988 Dec; (12):8-11. PubMed ID: 3245180
    [No Abstract]   [Full Text] [Related]  

  • 48. Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction who receive propranolol.
    Kostis JB; Wilson AC; Sanders MR; Byington RP
    Am J Cardiol; 1988 May; 61(13):975-8. PubMed ID: 3284322
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The use of beta-blocking agents in acute cardiac infarct].
    Mangiameli S; Circo A; Galassi A
    Boll Soc Ital Cardiol; 1975; 20(4):315-9. PubMed ID: 1231910
    [No Abstract]   [Full Text] [Related]  

  • 50. Propranolol in patients with acute myocardial infarction at the Royal Melbourne Hospital from 1965: a review.
    Sloman G; Hunt D; Ross D
    Postgrad Med J; 1976; 52 Suppl 4():150-2. PubMed ID: 967770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of prolonged ventricular repolarization following myocardial infarction: the BHAT experience. The BHAT Study Group.
    Peters RW; Byington RP; Barker A; Yusuf S
    J Clin Epidemiol; 1990; 43(2):167-72. PubMed ID: 2406377
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The long-term outcome of patients who suffered and survived an acute myocardial infarction in the midst of recurrent attacks of variant angina.
    Madias JE
    Clin Cardiol; 1986 Jun; 9(6):277-84. PubMed ID: 3720051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined effect of propranolol and nifedipine on infarct size in dogs.
    Wu GL; Chen SG; Jia DL
    Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(3):145-9. PubMed ID: 3422999
    [No Abstract]   [Full Text] [Related]  

  • 54. [Phase structure of cardiac cycle during the 1st few hours of myocardial infarct].
    Shvaro SV
    Klin Med (Mosk); 1977 Mar; 55(3):30-4. PubMed ID: 865021
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of obzidan on coronary blood flow in patients with the hyperkinetic type of hemodynamics in the acute period of myocardial infarct].
    Bogatyrev IV; Vakhliaev VD; Makolkin VI; Syrkin AL
    Kardiologiia; 1988 Aug; 28(8):52-5. PubMed ID: 3199656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Ratio of electrical and electromechanical ventricular systoles in the acute period of myocardial infarct and its significance for the late prognosis of sudden death].
    Iosaeva KV; Bekauri VA; Areshidze TKh; Tabagua VI
    Kardiologiia; 1987 Jun; 27(6):83-7. PubMed ID: 3626288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evaluation of the lesion zone in the acute period of myocardial infarct].
    Ianovskiĭ AD; Sopil'niak BF; Sharafutdinova NIu; Zaval'naia EN
    Vrach Delo; 1978 Oct; (10):12-6. PubMed ID: 716345
    [No Abstract]   [Full Text] [Related]  

  • 58. Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study).
    Peters RW; Muller JE; Goldstein S; Byington R; Friedman LM
    Am J Cardiol; 1989 Jun; 63(20):1518-20. PubMed ID: 2729140
    [No Abstract]   [Full Text] [Related]  

  • 59. Propranolol in acute myocardial infarction. A multicentre trial.
    Lancet; 1966 Dec; 2(7479):1435-8. PubMed ID: 4163441
    [No Abstract]   [Full Text] [Related]  

  • 60. One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.
    Hansteen V; Møinichen E; Lorentsen E; Andersen A; Strøm O; Søiland K; Dyrbekk D; Refsum AM; Tromsdal A; Knudsen K; Eika C; Bakken J; Smith P; Hoff PI
    Br Med J (Clin Res Ed); 1982 Jan; 284(6310):155-60. PubMed ID: 6799077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.